DNAJB11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.730000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.298800E-01
Normal-vs-Stage2
1.401970E-01
Normal-vs-Stage3
6.236400E-01
Normal-vs-Stage4
2.207400E-01
Stage1-vs-Stage2
4.631800E-01
Stage1-vs-Stage3
7.890200E-01
Stage1-vs-Stage4
3.854400E-01
Stage2-vs-Stage3
3.688400E-01
Stage2-vs-Stage4
6.770200E-01
Stage3-vs-Stage4
4.584000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.043600E-01
Normal-vs-AfricanAmerican
8.171600E-02
Normal-vs-Asian
3.943600E-02
Caucasian-vs-AfricanAmerican
4.629600E-01
Caucasian-vs-Asian
2.972200E-01
AfricanAmerican-vs-Asian
9.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.897600E-01
Normal-vs-Female
1.572170E-01
Male-vs-Female
6.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.258400E-01
Normal-vs-Age(41-60Yrs)
1.124370E-01
Normal-vs-Age(61-80Yrs)
2.359200E-01
Normal-vs-Age(81-100Yrs)
5.824000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.428200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.490400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.409000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.566100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.790000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.364400E-01
Normal-vs-Daily Drinker
2.730400E-01
Normal-vs-Weekly Drinker
8.352000E-02
Normal-vs-Occasional Drinker
1.602210E-01
Normal-vs-Social Drinker
2.581400E-01
Non Drinker-vs-Daily Drinker
4.531400E-01
Non Drinker-vs-Weekly Drinker
5.036200E-01
Non Drinker-vs-Occasional Drinker
2.042200E-01
Non Drinker-vs-Social Drinker
9.797600E-01
Daily Drinker-vs-Weekly Drinker
1.436430E-01
Daily Drinker-vs-Occasional Drinker
8.449800E-02
Daily Drinker-vs-Social Drinker
4.959000E-01
Weekly Drinker-vs-Occasional Drinker
5.703600E-01
Weekly Drinker-vs-Social Drinker
5.671000E-01
Occasional Drinker-vs-Social Drinker
3.119200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.618800E-01
Normal-vs-Grade 2
1.905240E-01
Normal-vs-Grade 3
1.464640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.385800E-01
Grade 1-vs-Grade 3
1.086420E-01
Grade 1-vs-Grade 4
5.618800E-01
Grade 2-vs-Grade 3
3.931200E-01
Grade 2-vs-Grade 4
1.905240E-01
Grade 3-vs-Grade 4
1.464640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.570200E-01
Normal-vs-NonDiabetic
1.705450E-01
Diabetic-vs-NonDiabetic
1.472590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.176400E-02
Normal-vs-NoPancreatitis
2.078200E-01
Pancreatitis-vs-NoPancreatitis
4.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.518580E-01
Normal-vs-N1
1.618800E-01
N0-vs-N1
6.172400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.329700E-02
Normal-vs-TP53-NonMutant
3.585800E-01
TP53-Mutant-vs-TP53-NonMutant
1.596420E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
